NCT04025580View on ClinicalTrials.gov

Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Healthy Volunteer
Interventions
BIOLOGICAL

Flucelvax

Seasonal influenza vaccine

BIOLOGICAL

Fluvirin

Seasonal influenza vaccine

BIOLOGICAL

Fluzone High Dose

Seasonal influenza vaccine for adults ages 65 and older

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT04025580 - Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine | Biotech Hunter | Biotech Hunter